Forte Biosciences, Inc. — Director's Dealing 2022

Jun 2, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Forte Biosciences, Inc. (FBRX)
CIK: 0001419041
Period of Report: 2022-06-01

Reporting Person: Doberstein Stephen K (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-01	Stock Option (right to buy)	$1.27	A	25000	Acquired	2032-06-01	Common Stock (25000)	Direct

Footnotes

F1: Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, the shares subject to the option shall vest in equal monthly installments over the twelve (12) months following the Date of Grant, provided that the shares subject to the option shall be fully vested on the date of the Issuer's next annual stockholder meeting. "Date of Grant" shall mean June 1, 2022.